Teva Pharmaceutical Industries ( TEVA) is exploring strategic options for its animal-health business and might consider shedding the division.

Teva has retained Bear Stearns as its financial adviser to assist it in the review.

Shares of Israel-based Teva were down 1.6% at $47.21 Monday.

This article was written by a staff member of TheStreet.com.

More from Stocks

Cable Stock Investors Should Keep an Eye On Wireless Broadband's Rise

Cable Stock Investors Should Keep an Eye On Wireless Broadband's Rise

Get to Know Stacey Cunningham, the NYSE's First Female Chief in 226 Years

Get to Know Stacey Cunningham, the NYSE's First Female Chief in 226 Years

Video: Here's How Global Stocks Can Boost Your Portfolio

Video: Here's How Global Stocks Can Boost Your Portfolio

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span